Mitochondrial ferritin attenuates β-amyloid-induced neurotoxicity: reduction in oxidative damage through the Erk/P38

Wen-Shuang Wu1, Ya-Shuo Zhao, Zhen-Hua Shi

  • 1Laboratory of Molecular Iron Metabolism, College of Life Science, Hebei Normal University, Shijiazhuang, People's Republic of China.

Abstract

Insights

Mitochondrial ferritin (MtFt) protects neurons from Alzheimer's disease (AD) pathology. Upregulating MtFt reduces iron dysregulation, oxidative stress, and cell death, offering a potential new AD treatment strategy.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Mitochondrial ferritin (MtFt) is crucial for preventing neuronal damage by maintaining mitochondrial iron homeostasis.
  • Disruptions in iron regulation are implicated in the development of Alzheimer's disease (AD).

Purpose of the Study:

  • To investigate the neuroprotective potential of MtFt in an Alzheimer's disease model.
  • To explore MtFt's role in mitigating amyloid-beta (Aβ) induced neurotoxicity.

Main Methods:

  • An Alzheimer's disease model was established using Aβ(25-35) treatment in rats and neuronal cells.
  • Mitochondrial ferritin (MtFt) expression was manipulated (knockdown and overexpression) in neuronal models.
  • Key signaling pathways, including Erk and P38 kinase, were analyzed.

Main Results:

  • Knockdown of MtFt exacerbated Aβ(25-35)-induced neurotoxicity, characterized by iron dysregulation, oxidative stress, and apoptosis.
  • Overexpression of MtFt in SH-SY5Y cells prior to Aβ(25-35) treatment yielded protective effects.
  • MtFt inhibited P38 mitogen-activated protein kinase and activated extracellular signal-regulated kinase (Erk) signaling in response to Aβ(25-35).

Conclusions:

  • Mitochondrial ferritin (MtFt) demonstrates a significant neuroprotective role in Alzheimer's disease.
  • Modulating MtFt expression in neuronal cells presents a promising therapeutic strategy for AD.